- ISIS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $90.8 million.
- ISIS is up 2.6% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ISIS with the Ticky from Trade-Ideas. See the FREE profile for ISIS NOW at Trade-Ideas More details on ISIS: Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. Currently there are 4 analysts that rate Isis Pharmaceuticals a buy, 1 analyst rates it a sell, and 2 rate it a hold. The average volume for Isis Pharmaceuticals has been 2.0 million shares per day over the past 30 days. Isis has a market cap of $4.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.67 and a short float of 11.9% with 6.07 days to cover. Shares are down 0.2% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Isis Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.